James Neal

Mr. James R.
Neal is an Independent Director at Akari Therapeutics Plc, an Independent Director at Processa Pharmaceuticals, Inc., an Independent Director at Monterey Innovation Acquisition Corp.
and a Chief Executive Officer at XOMA (US) LLC.
He is on the Board of Directors at Akari Therapeutics Plc, Processa Pharmaceuticals, Inc. and Monterey Innovation Acquisition Corp.
Mr. Neal was previously employed as a Lead Independent Director by Peak Bio, Inc., a Chairman by Palisade Bio, Inc., a Chairman & Chief Executive Officer by XOMA Corp., a President & Chief Executive Officer by Entelos, Inc., a Chief Executive Officer & Director by Iconix Biosciences, Inc., an EVP-Sales, Marketing & Business Development by Incyte Genomics Inc. /Micoarray Operations/, a Principal by Monsanto AG Co., a General Manager by The Solaris Group, a Partner by Eli Lilly & Co. Ltd., a Partner by GlaxoSmithKline Pharmaceuticals SA (Belgium), a Chairman by Seneca Biopharma, Inc., and a Chief Executive Officer by US Food & Drug Administration.
He also served on the board at Leading Biosciences, Inc. He received his undergraduate degree from the University of Manitoba, a graduate degree from the University of Manitoba and an MBA from Washington University in St. Louis.